Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate in Women of Childbearing Age – MarketWatch

April 29, 2014 2:15 pm

Comments are closed here.

Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now